-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Elevation Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
- Elevation Oncology, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$9.87 M, a 41.1% increase year-over-year.
- Elevation Oncology, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$38.6 M, a 58.9% increase year-over-year.
- Elevation Oncology, Inc. annual Operating Income (Loss) for 2023 was -$45.4 M, a 51.9% increase from 2022.
- Elevation Oncology, Inc. annual Operating Income (Loss) for 2022 was -$94.5 M, a 195% decline from 2021.
- Elevation Oncology, Inc. annual Operating Income (Loss) for 2021 was -$32 M, a 85.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)